Skip to main content
. 2006 Jul 25;95(3):266–271. doi: 10.1038/sj.bjc.6603279

Figure 2.

Figure 2

Overall survival of patients with high-risk endometrial carcinoma (stage IcG3, IIG3 with myometrial invasion >50%, and III) receiving adjuvant radiotherapy (Radio) or chemotherapy (Chemio). Five-year overall survival was 69% and 66% respectively for adjuvant radiotherapy and chemotherapy.